Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar 6;109(10):3623-7.
doi: 10.1073/pnas.1121383109. Epub 2012 Feb 2.

Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity

Affiliations
Review

Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity

Richard Malley et al. Proc Natl Acad Sci U S A. .

Abstract

For prevention of Streptococcus pneumoniae (pneumococcus) infections in infancy, protein-conjugated capsular polysaccharide vaccines provide serotype-specific, antibody-mediated immunity but do not cover all of the 90+ capsule serotypes. Therefore, microbiologists have sought protective noncapsular antigens common to all strains. Alternatively, we investigated killed cells of a noncapsulated strain, which expose many such common antigens. Given to mice intranasally, this vaccine elicits antibody-independent, CD4+ T lymphocyte-dependent accelerated clearance of pneumococci of various serotypes from the nasopharynx mediated by the cytokine IL-17A. Such immunity may reproduce the natural resistance that develops in infants before capsular antibodies arise. Given by injection, the killed cell vaccine induces bifunctional immunity: plasma antibodies protective against fatal pneumonia challenge, as well as IL-17A-mediated nasopharyngeal clearance. Human testing of this inexpensive candidate vaccine by intramuscular injection is planned. Bacterial cellular vaccines are complex--a challenge for reproducibility. However, when several known protective antigens were deleted, the killed pneumococcal vaccine was still protective. This antigenic redundancy may prevent vaccine escape variants by recombinational loss, which is frequent in pneumococcus. Biochemically defined immunogens with bifunctional activity have also been devised. These immunogens are three-component conjugates in which cell wall teichoic acid (a common antigen capable of T cell activation) is coupled to a genetic fusion of two common pneumococcal proteins: a protective surface antigen and a derivative of pneumolysin, which provides TLR4 agonist activity and induces antitoxic immunity. Such constructs induce accelerated clearance when given intranasally and induce both immune mechanisms when injected. The defined composition permits analysis of structure-function activity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: R.M. is a member of the scientific board of Genocea Biosciences.

Similar articles

Cited by

References

    1. O'Brien KL, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet. 2009;374:893–902. - PubMed
    1. Tomasz A. Choline in the cell wall of a bacterium: Novel type of polymer-linked choline in Pneumococcus. Science. 1967;157:694–697. - PubMed
    1. Tomasz A. Surface components of Streptococcus pneumoniae. Rev Infect Dis. 1981;3:190–211. - PubMed
    1. Fischer H, Tomasz A. Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae. J Bacteriol. 1985;163:46–54. - PMC - PubMed
    1. Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis. 1985;151:535–540. - PubMed